Evidence map›Paper›PMID 41681729›Full record

ArticleDiagnostics (Basel, Switzerland)2026

Taking High-Tech to the Field: Leukemia Diagnosis in Pediatric Mexican Patients from Vulnerable and Remote Regions.

Dalia Ramírez-Ramírez, Gabriela Zamora-Herrera, Rubí Romo-Rodríguez, Miguel Cuéllar Mendoza, Karen Ayala-Contreras, Enrique López Aguilar, Marta Zapata-Tarrés, Rosana Pelayo

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dalia Ramírez-RamírezLaboratorio de Citómica del Cáncer Infantil, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla 74360, Mexico.ORCID 0000-0002-2740-0317
Gabriela Zamora-HerreraLaboratorio de Citómica del Cáncer Infantil, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla 74360, Mexico.ORCID 0000-0002-5571-679X
Rubí Romo-RodríguezLaboratorio de Citómica del Cáncer Infantil, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla 74360, Mexico.ORCID 0000-0002-3715-2337
Miguel Cuéllar MendozaComisión Coordinadora de Institutos Nacionales de Salud y Hospitales de Alta Especialidad (CCINSHAE), Secretaria de Salud, Mexico City 11400, Mexico.ORCID 0000-0002-5236-4653
Karen Ayala-ContrerasLaboratorio de Citómica del Cáncer Infantil, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla 74360, Mexico.
Enrique López AguilarCoordinación de Atención Oncológica, Instituto Mexicano del Seguro Social, Mexico City 07760, Mexico.
Marta Zapata-TarrésSecretaria de Salud, Mexico City 11400, Mexico.ORCID 0000-0002-0737-924X
Rosana PelayoLaboratorio de Citómica del Cáncer Infantil, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla 74360, Mexico.ORCID 0000-0003-3401-9757

Funding

Consejo Nacional de Innovación, Ciencia y Tecnología 302994
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute leukemiaimmunophenotypinglow- and middle-income countriespediatric oncologytranslational research

Identifiers

PMID41681729
PMCPMC12896843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.